Mrs Amy Jo O'neill, APRN, CRNP-PMH | |
1443 Livingston Sq, Bel Air, MD 21015-1452 | |
(443) 987-1360 | |
(443) 987-1360 |
Full Name | Mrs Amy Jo O'neill |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 1443 Livingston Sq, Bel Air, Maryland |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831851021 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | R167588 (Maryland) | Secondary |
363LP0808X | Nurse Practitioner - Psychiatric/mental Health | R167588 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Amy Jo O'neill, APRN, CRNP-PMH 1308 Continental Dr Ste A, Abingdon, MD 21009-2304 Ph: (443) 987-1360 | Mrs Amy Jo O'neill, APRN, CRNP-PMH 1443 Livingston Sq, Bel Air, MD 21015-1452 Ph: (443) 987-1360 |
News Archive
A test to detect drug-resistant HIV strains in people with low levels of drug-resistant viral loads could help physicians provide more effective treatment earlier to HIV-positive people, according to a study published on Sunday in the online edition of the journal Nature Methods, BBC News reports.
An international team of researchers consisting of scientists from NUST MISIS and TU Dortmund University has developed a technology to study the behavior of orthopedic implants in laboratory conditions as close as possible to the human body.
People living with chronic low back pain (cLBP) are more likely to use illicit drugs - including marijuana, cocaine, heroin, and methamphetamine - compared to those without back pain, reports a study in Spine, published by Wolters Kluwer.
Canadian researchers collaborating in a large, international study played a key role in identifying four new genes for colorectal cancer.
The first study of uterine fibroid embolization to treat post-menopausal women shows that the non-surgical treatment was technically successful in 100 percent of patients, and improved bulk-related symptoms in 92 percent of the women.
› Verified 7 days ago